A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
CONTEXT: Non-islet cell tumor hypoglycemia (NICTH) results from the hypersecretion of pro-IGF-II by a large, usually mesenchymal tumor. Detection of pro-IGF-II in serum is a potential tumor marker in these patients. OBJECTIVE: The aim of this study was to validate a rapid and reliable method for de...
Main Authors: | Miraki-Moud, F, Grossman, AB, Besser, M, Monson, J, Camacho-Hübner, C |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2005
|
Títulos similares
-
Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
por: Miraki-Moud, F, et al.
Publicado: (2001) -
Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly.
por: Jenkins, P, et al.
Publicado: (2000) -
Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro.
por: Korbonits, M, et al.
Publicado: (1996) -
Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
por: le Roux, C, et al.
Publicado: (2002) -
Insulin-like growth factor-I (IGF-I) as a risk factor for colonic adenomas in patients with acromegaly.
por: Jenkins, P, et al.
Publicado: (1998)